Contract manufacturer Access Business Group has signed a research agreement with Interleukin Genetics to accelerate the development of innovative products in high potential markets such as anti-aging.
As part of the $1.2m deal Interleukin Genetics will seek to identify genetic factors that influence skin appearance in order to help Access Business Group to develop effective anti-aging products.
The anti-aging market continues to be one of the highest growth areas in the cosmetics industry and consumers are willing to pay top dollar for products that really work.
Scientists are working hard to develop products that successfully combat the signs of skin aging in order to help manufacturers bite deeper into the growing market.
Anti-aging products have been flying off the shelves for years and sales are expected to continue to grow at double-digit rates in the next few years, according to Interleukin Genetics.
Companies looking to develop innovative products in the anti-aging market are temporarily turning away from formulations in order to build their understanding of the process of skin aging.
Proctor & Gamble
For example Proctor & Gamble Beauty presented two studies on the genetics of skin aging at the 21st World Congress of Dermatology in Buenos Aries in October.
The P&G researchers said much descriptive research has been done to characterize the structural changes associated with skin aging but little is known about the genes behind it.
By exploring the genetic factors behind skin aging the company hopes to develop treatments that interrupt the processes that contribute to skin aging and support the skin's own healing process.
In particular the researchers were looking to focus on any differences between photo-aging (aging caused by environmental factors) and intrinsic aging (aging caused by nature and time).
The study concludes that although there is a similar pattern in both photo-aged and intrinsically aged skin, photo-aging appears to speed up and intensify many of the processes